Acadia Pharmaceuticals reported $-44000000 in EBITDA for its second fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -44M 45M
Adamas Pharmaceuticals ADMS:US $ -8M 5M
Alexion Pharmaceuticals ALXN:US $ 777.5M 44.6M
ALKERMES ALKS:US $ 9.91M 23.24M
Alnylam Pharmaceuticals ALNY:US $ -216.63M 25.97M
Biogen BIIB:US $ 1293.5M 829.7M
Biomarin Pharmaceutical BMRN:US $ -16.91M 85.25M
Bristol Myers Squibb BMY:US $ 4210M 401M
Corcept Therapeutics CORT:US $ 35M 2M
Cytokinetics CYTK:US $ 5.72M 37.66M
Eisai 4523:JP Y 40801M 19931M
Eli Lilly And LLY:US $ 1763M 213.6M
Gw Pharmaceuticals GWPH:US $ -9.09M 2.91M
Intercept Pharmaceuticals ICPT:US $ -51.22M 31.46M
Johnson & Johnson JNJ:US $ 8019M 2082M
Neurocrine Biosciences NBIX:US $ 124M 63M
Pfizer PFE:US $ 5103M 939M
Prothena PRTA:US -30446000 4.11M
Ptc Therapeutics PTCT:US $ -125.24M 41.48M
Sarepta Therapeutics SRPT:US $ -132M 20M
Seattle Genetics SGEN:US $ 653.64M 732.26M
Ultragenyx Pharmaceutical RARE:US $ -59.87M 57.94M
Vanda Pharmaceuticals VNDA:US $ 9.88M 9.29M
Vertex Pharmaceuticals VRTX:US $ 753.93M 5.28M
YTE INCY:US $ 262.67M 904.82M
Zogenix ZGNX:US $ -70M 24M